Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Florence Scher"'
Publikováno v:
Drug Design, Development and Therapy. 13:1535-1543
Previous reports have described the appearance of systemic lupus erythematosus (SLE) cases following interferon-α (IFN-α) therapy, IFN-regulated gene expression is significantly increased in SLE, and an association between SLE and gene variants bel
Publikováno v:
Revue du Rhumatisme
Revue du Rhumatisme, Elsevier, 2019, 86, pp.573-581. ⟨10.1016/j.rhum.2019.08.005⟩
Revue du Rhumatisme, 2019, 86, pp.573-581. ⟨10.1016/j.rhum.2019.08.005⟩
Revue du Rhumatisme, Elsevier, 2019, 86, pp.573-581. ⟨10.1016/j.rhum.2019.08.005⟩
Revue du Rhumatisme, 2019, 86, pp.573-581. ⟨10.1016/j.rhum.2019.08.005⟩
International audience; D’importants progrès ont été réalisés dans le diagnostic et la prise en charge thérapeutique du lupus érythémateux systémique (LES) au cours de ces dernières décennies. Après plus de onze siècles d’incertitude
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dbbf60fffc53013b868ad392906005e
https://hal.archives-ouvertes.fr/hal-03488972
https://hal.archives-ouvertes.fr/hal-03488972
Publikováno v:
Joint Bone Spine
Joint Bone Spine, Elsevier Masson, 2019, 86, pp.429-436. ⟨10.1016/j.jbspin.2018.09.004⟩
Joint Bone Spine, Elsevier Masson, 2019, 86, pp.429-436. ⟨10.1016/j.jbspin.2018.09.004⟩
There have been many advances in the diagnosis and therapeutic management of systemic lupus erythematosus (SLE) over the past decades. Following more than eleven centuries of therapeutic uncertainty, the discovery of the therapeutic properties of glu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17578d898aff9b2ba121b8c93697e1ea
https://hal.archives-ouvertes.fr/hal-03486436
https://hal.archives-ouvertes.fr/hal-03486436
Publikováno v:
Autoimmunity Reviews
Autoimmunity Reviews, Elsevier, 2019, 18, pp.576-582. ⟨10.1016/j.autrev.2018.12.008⟩
Autoimmunity Reviews, Elsevier, 2019, 18, pp.576-582. ⟨10.1016/j.autrev.2018.12.008⟩
To date, no immunomodulatory drug has proved efficacious in primary Sjogren's syndrome (pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of clinical involvements (glandular/extraglandular involvement), to the la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384cf8144ff4ed8920fed7d0391c22ca
https://hal.archives-ouvertes.fr/hal-03484634/document
https://hal.archives-ouvertes.fr/hal-03484634/document
Autor:
Pauline Soulas-Sprauel, Marianne Rivière, Rose-Marie Javier, Anne-Sophie Korganow, Aurélien Guffroy, Laurent Arnaud, Renaud Felten, Christelle Sordet, Florence Scher, P.E. Gavand, Thierry Martin, Vincent Poindron, Flora Sagez
Publikováno v:
Lupus science & medicine
Lupus science & medicine, BMJ, 2019, 6 (1), ⟨10.1136/lupus-2018-000303⟩
Lupus Science & Medicine
Lupus science & medicine, BMJ, 2019, 6 (1), ⟨10.1136/lupus-2018-000303⟩
Lupus Science & Medicine
From a 1-year survival of less than 50% before the discovery of glucocorticoids to over 90% at 10 years in most dedicated centres, the spectrum of SLE has profoundly evolved. Despite this improvement, several major challenges currently remain. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208810d9fb09a311611b626832ac96b6
Autor:
Laurent Arnaud, Jean Sibilia, Florence Scher, Jacques-Eric Gottenberg, François Chasset, Elida Dervovic, Renaud Felten
Publikováno v:
Autoimmunity reviews. 17(8)
Currently, Systemic Lupus Erythematosus (SLE) therapies range from antimalarials to glucocorticoids, in addition to immunosupressive agents or biologics such as rituximab or belimumab, when needed. Several unmet needs remain in the treatment SLE and